Wasatch Advisors LP reduced its position in Novanta Inc. (NASDAQ:NOVT – Free Report) by 0.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 996,832 shares of the technology company’s stock after selling 9,479 shares during the period. Wasatch Advisors LP owned about 2.78% of Novanta worth $152,286,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also bought and sold shares of NOVT. Sanctuary Advisors LLC acquired a new stake in shares of Novanta in the third quarter valued at approximately $232,000. KBC Group NV lifted its holdings in Novanta by 41.6% during the 4th quarter. KBC Group NV now owns 1,500 shares of the technology company’s stock valued at $229,000 after purchasing an additional 441 shares during the last quarter. Exchange Traded Concepts LLC boosted its position in Novanta by 4.0% during the fourth quarter. Exchange Traded Concepts LLC now owns 120,566 shares of the technology company’s stock worth $18,419,000 after purchasing an additional 4,648 shares during the period. Proficio Capital Partners LLC acquired a new position in shares of Novanta in the fourth quarter valued at $5,298,000. Finally, Zions Bancorporation N.A. increased its holdings in shares of Novanta by 21.2% in the fourth quarter. Zions Bancorporation N.A. now owns 14,211 shares of the technology company’s stock valued at $2,171,000 after purchasing an additional 2,486 shares during the last quarter. Institutional investors own 98.35% of the company’s stock.
Novanta Price Performance
Novanta stock opened at $114.09 on Wednesday. The company has a market capitalization of $4.10 billion, a price-to-earnings ratio of 68.32 and a beta of 1.42. The company has a current ratio of 2.79, a quick ratio of 1.81 and a debt-to-equity ratio of 0.61. Novanta Inc. has a 12 month low of $98.76 and a 12 month high of $187.12. The stock’s 50 day moving average is $133.29 and its 200-day moving average is $153.00.
Analyst Upgrades and Downgrades
Separately, Robert W. Baird reduced their target price on shares of Novanta from $169.00 to $160.00 and set a “neutral” rating for the company in a report on Monday, March 3rd.
View Our Latest Stock Report on NOVT
Novanta Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Read More
- Five stocks we like better than Novanta
- Technology Stocks Explained: Here’s What to Know About Tech
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- A Deeper Look at Bid-Ask Spreads
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- Investing In Preferred Stock vs. Common Stock
- Congress! Who Traded What During the Tariff-Induced MeltdownÂ
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.